Chronic hepatitis E: A brief review

World Journal of Hepatology

Volumn 7, Issue 19, 2015, Pages 2194-2201

  Murali, Arvind R ^a   Kotwal, Vikram ^b   Chawla, Saurabh ^a,c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b St Marys Hospital Decatur   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic liver disease; Hematological malignancies; Hepatitis E virus; Immunosuppression; Solid organ transplantation

Indexed keywords

EID: 84941114762     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i19.2194     Document Type: Review

References (67)

1. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology 2012; 142: 1388-1397.e1 [PMID: 22537448 DOI: 10.1053/j. gastro.2012.02.014].
2. Smith DB, Simmonds P, Jameel S, Emerson SU, Harrison TJ, Meng XJ, Okamoto H, Van der Poel WH, Purdy MA. Consensus proposals for classification of the family Hepeviridae. J Gen Virol 2014; 95: 2223-2232 [PMID: 24989172 DOI: 10.1099/vir.0.068429-0].
3. Panda SK, Thakral D, Rehman S. Hepatitis E virus. Rev Med Virol 2007; 17: 151-180 [PMID: 17051624 DOI: 10.1002/rmv.522].
4. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494-503 [PMID: 18192058 DOI: 10.1016/j.jhep.2007.12.008].
5. Bouamra Y, Gérolami R, Arzouni JP, Grimaud JC, Lafforgue P, Nelli M, Tivoli N, Ferretti A, Motte A, Colson P. Emergence of autochthonous infections with hepatitis E virus of genotype 4 in Europe. Intervirology 2014; 57: 43-48 [PMID: 24157452 DOI: 10.1159/000354801].
6. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55: 988-997 [PMID: 22121109 DOI: 10.1002/ hep.25505].
7. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362: 371-373 [PMID: 12907011 DOI: 10.1016/S0140-6736(03)14025-1].
8. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, Raoult D, Gerolami R. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202: 825-834 [PMID: 20695796 DOI: 10.1086/655898].
9. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, Haynes JS, Thacker BJ, Emerson SU. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997; 94: 9860-9865 [PMID: 9275216].
10. Schlauder GG, Dawson GJ, Erker JC, Kwo PY, Knigge MF, Smalley DL, Rosenblatt JE, Desai SM, Mushahwar IK. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol 1998; 79 (Pt 3): 447-456 [PMID: 9519822].
11. Aggarwal R, Naik SR. Hepatitis E: intrafamilial transmission versus waterborne spread. J Hepatol 1994; 21: 718-723 [PMID: 7890884].
12. Somani SK, Aggarwal R, Naik SR, Srivastava S, Naik S. A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection. J Viral Hepat 2003; 10: 446-449 [PMID: 14633178].
13. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345: 1025-1026 [PMID: 7723501].
14. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, Teo CG. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 2006; 16: 79-83 [PMID: 16623913 DOI: 10.1111/j.1365-3148.2006.00652.x].
15. Abe K, Li TC, Ding X, Win KM, Shrestha PK, Quang VX, Ngoc TT, Taltavull TC, Smirnov AV, Uchaikin VF, Luengrojanakul P, Gu H, El-Zayadi AR, Prince AM, Kikuchi K, Masaki N, Inui A, Sata T, Takeda N. International collaborative survey on epidemiology of hepatitis E virus in 11 countries. Southeast Asian J Trop Med Public Health 2006; 37: 90-95 [PMID: 16771218].
16. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, Farrington L, Hamad N, Sieberhagen C, Ellis V, Mitchell J, Hussaini SH, Banks M, Ijaz S, Bendall RP. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008; 20: 784-790 [PMID: 18617784 DOI: 10.1097/MEG. 0b013e3282f5195 a].
17. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200: 48-56 [PMID: 19473098 DOI: 10.1086/599319].
18. Drobeniuc J, Favorov MO, Shapiro CN, Bell BP, Mast EE, Dadu A, Culver D, Iarovoi P, Robertson BH, Margolis HS. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 2001; 184: 1594-1597 [PMID: 11740735 DOI: 10.1086/324566].
19. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40: 117-122 [PMID: 11773103].
20. Olsen B, Axelsson-Olsson D, Thelin A, Weiland O. Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls. Scand J Infect Dis 2006; 38: 55-58 [PMID: 16338839 DOI: 10.1080/00365540500321470].
21. Galiana C, Fernández-Barredo S, García A, Gómez MT, Pérez-Gracia MT. Occupational exposure to hepatitis E virus (HEV) in swine workers. Am J Trop Med Hyg 2008; 78: 1012-1015 [PMID: 18541786].
22. Bouwknegt M, Engel B, Herremans MM, Widdowson MA, Worm HC, Koopmans MP, Frankena K, de Roda Husman AM, De Jong MC, Van Der Poel WH. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands. Epidemiol Infect 2008; 136: 567-576 [PMID: 17578603 DOI: 10.1017/S0950268807008941].
23. Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2013; 10: 24-33 [PMID: 23026902 DOI: 10.1038/nrgastro. 2012.187].
24. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-817 [PMID: 18287603 DOI: 10.1056/NEJMoa0706992].
25. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358: 859-860 [PMID: 18287615 DOI: 10.1056/NEJMc0708687].
26. Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J. How should hepatitis E virus infection be defined in organ-transplant recipients? Am J Transplant 2013; 13: 1935-1936 [PMID: 23659713 DOI: 10.1111/ajt.12253].
27. Baylis SA, Hanschmann KM, Blümel J, Nübling CM. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49: 1234-1239 [PMID: 21307208 DOI: 10.1128/ JCM. 02578-10].
28. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet 2012; 379: 2477-2488 [PMID: 22549046 DOI: 10.1016/S0140-6736(11)61849-7].
29. Geng Y, Zhang H, Huang W, J Harrison T, Geng K, Li Z, Wang Y. Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon 2014; 14: e15618 [PMID: 24596581 DOI: 10.5812/hepatmon.15618].
30. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-1489 [PMID: 21354150 DOI: 10.1053/j.gastro.2011.02.050].
31. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Izopet J. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202: 835-844 [PMID: 20695798 DOI: 10.1086/655899].
32. Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, Dalton HR. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17: 173-179 [PMID: 21291585 DOI: 10.3201/eid1702.100856].
33. Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau-Desangles I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012; 93: 617-623 [PMID: 22298032 DOI: 10.1097/TP.0b013e318245f14c].
34. Taton B, Moreau K, Lepreux S, Bachelet T, Trimoulet P, De Ledinghen V, Pommereau A, Ronco P, Kamar N, Merville P, Couzi L. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation. Transpl Infect Dis 2013; 15: E211-E215 [PMID: 24103101 DOI: 10.1111/tid.12143].
35. Pischke S, Behrendt P, Manns MP, Wedemeyer H. HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E. Lancet Infect Dis 2014; 14: 678-679 [PMID: 25056019 DOI: 10.1016/S1473-3099(14)70823-0].
36. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, Koopmans MP. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14: 547-553 [PMID: 18383084 DOI: 10.1002/lt.21480].
37. Gérolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50: 622-624 [PMID: 19157619 DOI: 10.1016/j.jhep.2008.12.008].
38. Riezebos-Brilman A, Puchhammer-Stöckl E, van der Weide HY, Haagsma EB, Jaksch P, Bejvl I, Niesters HG, Verschuuren EA. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 2013; 32: 341-346 [PMID: 23415316 DOI: 10.1016/j.healun.2012.11.027].
39. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, Reimerink JH, Koopmans MP. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15: 1225-1228 [PMID: 19790147 DOI: 10.1002/ lt.21819].
40. Lhomme S, Abravanel F, Dubois M, Sandres-Saune K, Rostaing L, Kamar N, Izopet J. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol 2012; 86: 10006-10014 [PMID: 22761386 DOI: 10.1128/JVI. 01003-12].
41. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Krüger DH, Berg T, Hofmann J. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012; 56: 500-502 [PMID: 21798217 DOI: 10.1016/ j.jhep.2011.06.021].
42. Sagnelli E, Sagnelli C, Pisaturo M, Coppola N. Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection. World J Gastroenterol 2014; 20: 6707-6715 [PMID: 24944463 DOI: 10.3748/wjg.v20.i22.6707].
43. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, Nicand E. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150: 430-431 [PMID: 19293084].
44. le Coutre P, Meisel H, Hofmann J, Röcken C, Vuong GL, Neuburger S, Hemmati PG, Dörken B, Arnold R. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58: 699-702 [PMID: 19359434 DOI: 10.1136/gut.2008.165571].
45. Tavitian S, Péron JM, Huynh A, Mansuy JM, Ysebaert L, Huguet F, Vinel JP, Attal M, Izopet J, Récher C. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol 2010; 49: 141-144 [PMID: 20678959 DOI: 10.1016/ j.jcv.2010.06.016].
46. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361: 1025-1027 [PMID: 19726781 DOI: 10.1056/ NEJMc0903778].
47. Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gérolami R. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat 2011; 18: 227-228 [PMID: 20384963 DOI: 10.1111/j.1365-2893.2010.01311.x].
48. Jagjit Singh GK, Ijaz S, Rockwood N, Farnworth SP, Devitt E, Atkins M, Tedder R, Nelson M. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect 2013; 66: 103-106 [PMID: 22166370 DOI: 10.1016/j.jinf.2011.11.027].
49. Kenfak-Foguena A, Schöni-Affolter F, Bürgisser P, Witteck A, Darling KE, Kovari H, Kaiser L, Evison JM, Elzi L, Gurter-De La Fuente V, Jost J, Moradpour D, Abravanel F, Izpopet J, Cavassini M. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011; 17: 1074-1078 [PMID: 21749774 DOI: 10.3201/eid/1706.101067].
50. Madejón A, Vispo E, Bottecchia M, Sánchez-Carrillo M, García-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009; 16: 895-896 [PMID: 19413691 DOI: 10.1111/j.1365-2893.2009.01138.x].
51. Sellier P, Mazeron MC, Tesse S, Badsi E, Evans J, Magnier JD, Sanson-Le-Pors MJ, Bergmann JF, Nicand E. Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels. Virol J 2011; 8: 171 [PMID: 21496215 DOI: 10.1186/1743-422X-8-171].
52. Kaba M, Richet H, Ravaux I, Moreau J, Poizot-Martin I, Motte A, Nicolino-Brunet C, Dignat-George F, Ménard A, Dhiver C, Brouqui P, Colson P. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011; 83: 1704-1716 [PMID: 21837786 DOI: 10.1002/jmv.22177].
53. Grewal P, Kamili S, Motamed D. Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology 2014; 59: 347-348 [PMID: 23913727 DOI: 10.1002/hep.26636].
54. Höner zu Siederdissen C, Pischke S, Schlue J, Deterding K, Hellms T, Schuler-Lüttmann S, Schwarz A, Manns MP, Cornberg M, Wedemeyer H. Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection. Hepatology 2014; 60: 1112-1113 [PMID: 24375747 DOI: 10.1002/ hep.26987].
55. González Tallón AI, Moreira Vicente V, Mateos Lindemann ML, Achécar Justo LM. [Chronic hepatitis E in an immunocompetent patient]. Gastroenterol Hepatol 2011; 34: 398-400 [PMID: 21571397 DOI: 10.1016/j.gastrohep.2011.02.011].
56. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssière L, Cointault O, Ribes D, Cardeau I, Nogier MB, Mansuy JM, Muscari F, Peron JM, Izopet J, Rostaing L. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010; 89: 353-360 [PMID: 20145528 DOI: 10.1097/TP. 0b013e3181c 4096c].
57. Wang Y, Zhou X, Debing Y, Chen K, Van Der Laan LJ, Neyts J, Janssen HL, Metselaar HJ, Peppelenbosch MP, Pan Q. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology 2014; 146: 1775-1783 [PMID: 24582714 DOI: 10.1053/j.gastro.2014.02.036].
58. Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I, Mansuy JM, Selves J, Peron JM, Otal P, Muscari F, Izopet J. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50: e30-e33 [PMID: 20113176 DOI: 10.1086/650488].
59. Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tessé S, Thervet E, Mouthon L, Sogni P, Pol S. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153: 85-89 [PMID: 20547886 DOI: 10.7326/0003-4819-153-2-201 007200-00257].
60. Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D'Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014; 370: 1111-1120 [PMID: 24645943 DOI: 10.1056/NEJMoa1215246].
61. Dalton HR, Keane FE, Bendall R, Mathew J, Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011; 155: 479-480 [PMID: 21969351 DOI: 10.7326/0003-4819-1 55-7-201110040-00017].
62. Peters van Ton AM, Gevers TJ, Drenth JP. Antiviral therapy in chronic hepatitis E: a systematic review. J Viral Hepat 2015; Epub ahead of print [PMID: 25760481 DOI: 10.1111/jvh.12403].
63. Schielke A, Filter M, Appel B, Johne R. Thermal stability of hepatitis E virus assessed by a molecular biological approach. Virol J 2011; 8: 487 [PMID: 22040359 DOI: 10.1186/1743-422X-8-487].
64. Emerson SU, Arankalle VA, Purcell RH. Thermal stability of hepatitis E virus. J Infect Dis 2005; 192: 930-933 [PMID: 16088844 DOI: 10.1086/432488].
65. Shrestha MP, Scott RM, Joshi DM, Mammen MP, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK,David MP, Seriwatana J, Vaughn DW, Safary A, Endy TP, Innis BL. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: 895-903 [PMID: 17329696 DOI: 10.1056/ NEJMoa061847].
66. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ, Ai X, Hu YM, Tang Q, Yao X, Yan Q, Xian YL, Wu T, Li YM, Miao J, Ng MH, Shih JW, Xia NS. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebocontrolled, phase 3 trial. Lancet 2010; 376: 895-902 [PMID: 20728932 DOI: 10.1016/S0140-6736(10)61030-6].
67. Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, Guo M, Liu XH, Li JX, Yang CL, Tang Q, Jiang RJ, Pan HR, Li YM, Shih JW, Ng MH, Zhu FC, Xia NS. Long-term efficacy of a hepatitis E vaccine. N Engl J Med 2015; 372: 914-922 [PMID: 25738667 DOI: 10.1056/NEJMoa1406011].